Gotowa bibliografia na temat „Drug screenings”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Drug screenings”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Drug screenings"
O’Neil, Meghan M. "Drug Screenings in Practice". Federal Sentencing Reporter 36, nr 4 (1.04.2024): 212–17. http://dx.doi.org/10.1525/fsr.2024.36.4.212.
Pełny tekst źródłaLiang, Qiying, Peng Ma, Qi Zhang, Youjie Yin, Ping Wang, Saifei Wang, Yao Zhang, Ruolei Han i Hansong Deng. "A gum Arabic assisted sustainable drug delivery system for adult Drosophila". Biology Open 9, nr 6 (2.06.2020): bio052241. http://dx.doi.org/10.1242/bio.052241.
Pełny tekst źródłaPopova, Anna A., Claire Depew, Katya Manuella Permana, Alexander Trubitsyn, Ravindra Peravali, Jorge Ángel González Ordiano, Markus Reischl i Pavel A. Levkin. "Evaluation of the Droplet-Microarray Platform for High-Throughput Screening of Suspension Cells". SLAS TECHNOLOGY: Translating Life Sciences Innovation 22, nr 2 (15.11.2016): 163–75. http://dx.doi.org/10.1177/2211068216677204.
Pełny tekst źródłaVacchina, Paola, i Miguel A. Morales. "In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein". Antimicrobial Agents and Chemotherapy 58, nr 3 (6.01.2014): 1825–28. http://dx.doi.org/10.1128/aac.02224-13.
Pełny tekst źródłaHann, Christina. "Random Drug Screenings: Nothing to Lose?" American Pharmacy 27, nr 10 (październik 1987): 34–36. http://dx.doi.org/10.1016/s0160-3450(16)33340-2.
Pełny tekst źródłaWilliams, Petal Petersen, Catherine Mathews, Esmé Jordaan, Yukiko Washio, Mishka Terplan i Charles DH Parry. "Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa". Clinical Ethics 15, nr 4 (31.05.2020): 181–86. http://dx.doi.org/10.1177/1477750920928885.
Pełny tekst źródłaNguemeni Tiako, Max Jordan, Abby Dolan, Matthew Abrams, Kehinde Oyekanmi, Zachary Meisel i Shoshana V. Aronowitz. "Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements". JAMA Network Open 6, nr 6 (15.06.2023): e2318487. http://dx.doi.org/10.1001/jamanetworkopen.2023.18487.
Pełny tekst źródłaSalas-Sarduy, Emir, Gabriela T. Niemirowicz, Juan José Cazzulo i Vanina E. Alvarez. "Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds". Current Medicinal Chemistry 26, nr 36 (13.12.2019): 6672–86. http://dx.doi.org/10.2174/0929867326666190705160637.
Pełny tekst źródłaDegliesposti, Gianluca, Corinne Portioli, Marco Daniele Parenti i Giulio Rastelli. "BEAR, a Novel Virtual Screening Methodology for Drug Discovery". Journal of Biomolecular Screening 16, nr 1 (17.11.2010): 129–33. http://dx.doi.org/10.1177/1087057110388276.
Pełny tekst źródłaBintener, Tamara, Maria Pires Pacheco i Thomas Sauter. "Towards the routine use of in silico screenings for drug discovery using metabolic modelling". Biochemical Society Transactions 48, nr 3 (5.05.2020): 955–69. http://dx.doi.org/10.1042/bst20190867.
Pełny tekst źródłaRozprawy doktorskie na temat "Drug screenings"
Myers, Mason Thomas. "Combining Primary Specificity Screenings for Drug Discovery Targeting T-box Antiterminator RNA". Ohio University Honors Tutorial College / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ouhonors1619173211823351.
Pełny tekst źródłaGorgulla, Christoph [Verfasser]. "Free Energy Methods Involving Quantum Physics, Path Integrals, and Virtual Screenings : Development, Implementation and Application in Drug Discovery / Christoph Gorgulla". Berlin : Freie Universität Berlin, 2018. http://d-nb.info/1159900655/34.
Pełny tekst źródłaMavridis, Lazaros. "High throughput virtual drug screening using spherical harmonic molecular surface representations". Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=25936.
Pełny tekst źródłaBaker, Nicola Louise. "Screening for new natural drugs and drug resistance determinants in African trypanosomiasis". Thesis, London School of Hygiene and Tropical Medicine (University of London), 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590629.
Pełny tekst źródłaWolbers, Floor. "Apoptosis chip for drug screening". Enschede : University of Twente [Host], 2007. http://doc.utwente.nl/57881.
Pełny tekst źródłaLarson, Joeanna Lee. "Perinatal Drug Abuse Intervention: Policy Development for Drug Screening". ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/2555.
Pełny tekst źródłaGuimaraes, A. "Screening molecular interactions for drug discovery". Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1389941/.
Pełny tekst źródłaLi, Yifan. "Optimal pool size for pooled drug screening". Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=104708.
Pełny tekst źródłaNous addressons le problème de la determination des groupes de substances chimiques pour obtenir des nouveaux traitements. Le but est d'automatiser l'analyse des librairies des larges librairies chimiques et pharmacologiques. L'hypothese de base est qu'il y a un groupe de substances qui ont un effect positif sur une certaine maladie, mais on doit l'identifier par l'analyse d'un très large groupe de substances. Dans ce groupe, il y a aussi des substances qui peuvent masquer l'effet désirable. Nous proposons une formule pour calculer le nombre optimal de substances qu'on devrait tester à la meme fois. La conclusion surprenante est que ce nombre ne depend pas des erreures qu'on fait dans les mesurements. Nous etablissons aussi le nombre de combinaisons qu'on devrait tester pour identifier le groupe desiré. Nouspresentons aussi une approche Bayesienne qu'on peut utiliser quand le nombre des substances bloquant l'effect desiré n'est pas connu.
Pagnotta, Giorgia <1995>. "3D bioprinted organ models for drug screening". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2022. http://amsdottorato.unibo.it/10326/1/Pagnotta_Giorgia_tesi.pdf.
Pełny tekst źródłaPsaroudakis, G. "Virtual screening in drug design and model evaluation". Thesis, University of Essex, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422234.
Pełny tekst źródłaKsiążki na temat "Drug screenings"
Taha, Mutasem Omar. Virtual screening. Croatia: Intech, 2012.
Znajdź pełny tekst źródła1947-, Seethala Ramakrishna, i Fernandes P. B, red. Handbook of drug screening. New York: Marcel Dekker, 2001.
Znajdź pełny tekst źródłaNational Institute on Drug Abuse., red. Employee drug screening: Detection of drug use by urinalysis. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, 1986.
Znajdź pełny tekst źródła1952-, Teicher Beverly A., i Andrews Paul A, red. Anticancer drug development guide: Preclinical screening, clinical trials, and approval. Wyd. 2. Totowa, N.J: Humana Press, 2004.
Znajdź pełny tekst źródłaJörg, Hüser, red. High-throughput screening in drug discovery. Weinheim: Wiley-VCH, 2006.
Znajdź pełny tekst źródłaThompson, Emmanuel B. Drug bioscreening: Drug evaluation techniques in pharmacology. New York: VCH, 1990.
Znajdź pełny tekst źródłaHans-Joachim, Böhm, i Schneider Gisbert 1965-, red. Virtual screening for bioactive molecules. Weinheim: Wiley-VCH, 2000.
Znajdź pełny tekst źródłaDrug bioscreening: Fundamentals of drug evaluation techniques in pharmacology. Flushing, N.Y: Graceway Pub. Co., 1985.
Znajdź pełny tekst źródłaW, Erhardt P., i International Union of Pure and Applied Chemistry., red. Drug metabolism: Databases and high-throughput testing during drug design and development. Oxford: Blackwell Science, 1999.
Znajdź pełny tekst źródłaG, Welling Peter, Lasagna Louis 1923- i Banakar Umesh V. 1956-, red. The drug development process. New York: M. Dekker, 1996.
Znajdź pełny tekst źródłaCzęści książek na temat "Drug screenings"
Jung, Matthias, Juliane-Susanne Jung, Jovita Schiller i Insa S. Schroeder. "Disease-Specific Stem Cell Models for Toxicological Screenings and Drug Development". W Stem Cells in Toxicology and Medicine, 122–44. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119135449.ch7.
Pełny tekst źródłaBarh, Debmalya, Shoaib Ahmad i Atanu Bhattacharjee. "In Silico and Ultrahigh-Throughput Screenings (uHTS) in Drug Discovery: An Overview". W Pharmaceutical Biotechnology, 451–90. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527632909.ch18.
Pełny tekst źródłaMohty, Razan, i Arafat Tfayli. "General Oncology Care in Lebanon". W Cancer in the Arab World, 115–32. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-7945-2_8.
Pełny tekst źródłaCummins, David Jesse. "Pharmaceutical Drug Discovery: Designing the Blockbuster Drug". W Screening, 69–114. New York, NY: Springer New York, 2006. http://dx.doi.org/10.1007/0-387-28014-6_4.
Pełny tekst źródłaMacolino-Kane, Christine M., John R. Ciallella, Christopher A. Lipinski i Andrew G. Reaume. "Phenotypic Screening". W Drug Repositioning, 121–45. Boca Raton: CRC Press, [2017] | Series: Frontiers in Neurotherapeutics series: CRC Press, 2017. http://dx.doi.org/10.4324/9781315373669-7.
Pełny tekst źródłaHughes-Oliver, Jacqueline M. "Pooling Experiments for Blood Screening and Drug Discovery". W Screening, 48–68. New York, NY: Springer New York, 2006. http://dx.doi.org/10.1007/0-387-28014-6_3.
Pełny tekst źródłaDuong, Huynh P., Warunee Dansithong, Daniel R. Scoles i Stefan M. Pulst. "Advanced Gene-Targeting Methods to Generate Cell Line Models that Preserve Native Regulatory Elements for Efficient High-Throughput Drug Screenings". W 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6), 643–47. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4361-1_110.
Pełny tekst źródłaSantos Nascimento, Igor José dos, i Ricardo Olimpio de Moura. "Ligand and Structure-Based Drug Design (LBDD and SBDD): Promising Approaches to Discover New Drugs". W Applied Computer-Aided Drug Design: Models and Methods, 1–32. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815179934123010003.
Pełny tekst źródła"Drug Repositioning Using Genome-wide Screening and Systems Biology Approaches and Applications". W Cheminformatics and Bioinformatics at the Interface with Systems Biology, 31–51. Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781839166037-00031.
Pełny tekst źródła"Screening for Drugs". W Quick Reference Guide to Pediatric Care, 1246–49. American Academy of Pediatrics, 2005. http://dx.doi.org/10.1542/9781581106220-part01-screening-drug.
Pełny tekst źródłaStreszczenia konferencji na temat "Drug screenings"
Distinto, Simona, i Elias Maccioni. "In Silico Approaches for Drug Discovery Focus on Virtual Screenings". W Sinteza 2022. Beograd, Serbia: Singidunum University, 2022. http://dx.doi.org/10.15308/sinteza-2022-360-364.
Pełny tekst źródłaBramante, Simona, Vilja Pietiäinen, Lassi Paavolainen, Annukka Pasanen, Netta Mäkinen, Hanna-Riikka Heinonen, Pirjo Ikonen i in. "Abstract 1159: Development of uterine leiomyoma 3D in vitro models for high-throughput drug and chemical compound screenings: Towards personalized medicine". W Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1159.
Pełny tekst źródłaDereli-Korkut, Zeynep, i Sihong Wang. "Microfluidic Cell Arrays to Mimic 3D Tissue Microenvironment". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80411.
Pełny tekst źródłaMa, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin i Wei Li. "A Perfused Two-Chamber System for Anticancer Drug Screening". W ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.
Pełny tekst źródłaGeorge, Subin M., i Hyejin Moon. "Digital Microfluidic Platform for 3-D Tissue Based High Throughput Screening". W ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53995.
Pełny tekst źródłaFavreau, Peter, Cheri Pasch, Dustin Deming i Melissa Skala. "Autofluorescence metabolic drug screening in colorectal cancer spheroids". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/omp.2017.oms2d.4.
Pełny tekst źródłaChen, Ying-Ting, Ren-Guei Wu, Chung-Shi Yang i Fan-Gang Tseng. "Cocktail drug delivery chip for cancer drug screening". W TRANSDUCERS 2015 - 2015 18th International Solid-State Sensors, Actuators and Microsystems Conference. IEEE, 2015. http://dx.doi.org/10.1109/transducers.2015.7181028.
Pełny tekst źródłaFukunishi, Yoshifumi, Theodore E. Simos i George Maroulis. "Structure-based Drug Screening and Ligand-Based Drug Screening Toward Protein-Compound Network". W COMPUTATIONAL METHODS IN SCIENCE AND ENGINEERING: Theory and Computation: Old Problems and New Challenges. Lectures Presented at the International Conference on Computational Methods in Science and Engineering 2007 (ICCMSE 2007): VOLUME 1. AIP, 2007. http://dx.doi.org/10.1063/1.2836070.
Pełny tekst źródłaHagan, Daniel M., i Martin T. Hagan. "Virtual drug screening using neural networks". W 2016 International Joint Conference on Neural Networks (IJCNN). IEEE, 2016. http://dx.doi.org/10.1109/ijcnn.2016.7727252.
Pełny tekst źródłaKannam, Sridhar K., Matthew T. Downton, Natalie Gunn, Sung Cheol Kim, Priscilla R. Rogers, Christine Schieber, Julia S. Baldauf i in. "Nanosensors for next generation drug screening". W SPIE Micro+Nano Materials, Devices, and Applications, redaktorzy James Friend i H. Hoe Tan. SPIE, 2013. http://dx.doi.org/10.1117/12.2033737.
Pełny tekst źródłaRaporty organizacyjne na temat "Drug screenings"
McNeany, Karen I. USER S GUIDE FOR THE RANDOM DRUG SCREENING SYSTEM. Office of Scientific and Technical Information (OSTI), grudzień 2013. http://dx.doi.org/10.2172/1154773.
Pełny tekst źródłaAger, Arba L., i Jr. Screening and Evaluation of Experimental Antiparasitic Drugs. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 1991. http://dx.doi.org/10.21236/ada240647.
Pełny tekst źródłaYang, In H. Novel High-Throughput Drug Screening Platform for Chemotherapy-Induced Axonal Neuropathy. Fort Belvoir, VA: Defense Technical Information Center, maj 2014. http://dx.doi.org/10.21236/ada613177.
Pełny tekst źródłaYang, In H. Novel High-Throughput Drug Screening Platform for Chemotherapy-Induced Axonal Neuropathy. Fort Belvoir, VA: Defense Technical Information Center, maj 2013. http://dx.doi.org/10.21236/ada581346.
Pełny tekst źródłaJohnson, Corey, Colton James, Sarah Traughber i Charles Walker. Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex. University of Tennessee Health Science Center, lipiec 2021. http://dx.doi.org/10.21007/con.dnp.2021.0005.
Pełny tekst źródłaAger Jr, Arba L. The Screening and Evaluation of Experimental Antiparasitic Drugs. Fort Belvoir, VA: Defense Technical Information Center, sierpień 1990. http://dx.doi.org/10.21236/ada238551.
Pełny tekst źródłaBisoffi, Marco. Curcumin Based Drug Screening for Inhibitors of NF kappa B in a Cell Model of Prostate Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, luty 2008. http://dx.doi.org/10.21236/ada482629.
Pełny tekst źródłaTurpin, James A. Drug Development and Convervation of Biodiversity in West and Central Africa/in Vitro Antiviral Screening of Plant Extracts and Isolates. Fort Belvoir, VA: Defense Technical Information Center, listopad 2000. http://dx.doi.org/10.21236/ada383151.
Pełny tekst źródłaPeter W. Carr, K.M. Fuller, D.R. Stoll, L.D. Steinkraus, M.S. Pasha i Glenn G. Hardin. Fast Gradient Elution Reversed-Phase HPLC with Diode-Array Detection as a High Throughput Screening Method for Drugs of Abuse. Office of Scientific and Technical Information (OSTI), grudzień 2005. http://dx.doi.org/10.2172/892807.
Pełny tekst źródłaLehotay, Steven J., i Aviv Amirav. Ultra-Fast Methods and Instrumentation for the Analysis of Hazardous Chemicals in the Food Supply. United States Department of Agriculture, grudzień 2012. http://dx.doi.org/10.32747/2012.7699852.bard.
Pełny tekst źródła